Guidance for Intersect ENT (XENT)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2021 | N/A | N/A | $117.00M – 121.00M | $119.41M | = Maintained | Details |
| 2020 | N/A | N/A | $115.00M – 119.00M | $119.41M | = Maintained | Details |
| 2019 | N/A | N/A | $108.50M | $108.50M | = Maintained | Details |
| 2019 | N/A | N/A | $108.50M | $114.84M |  Lowered |
Details |
| 2019 | N/A | N/A | $113.00M – 117.00M | $125.25M | Lowered |
Details |
| 2019 | N/A | N/A | $123.00M – 127.00M | $127.24M | = Maintained | Details |
| Q1 2019 | N/A | N/A | $26.00M – 26.50M | $27.50M | = Maintained | Details |
| 2018 | N/A | N/A | $106.00M – 109.00M | $116.29M | Lowered |
Details |
| 2018 | N/A | N/A | $111.00M – 116.00M | N/A | = Maintained | Details |
| 2018 | N/A | N/A | $111.00M – 116.00M | $114.43M | = Maintained | Details |
| Q3 2018 | N/A | N/A | $23.80M – 24.30M | $27.57M | = Maintained | Details |
| 2017 | N/A | N/A | $89.00M – 91.00M | $88.04M | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | $22.50M – 22.70M | $21.73M | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
